In the last 12 months, insiders at Harmony Biosciences Holdings, Inc. ($HRMY) filed 176 transactions with the SEC: 0 open-market purchases totaling $0 and 33 sales totaling $290,993,407. Net insider sentiment: net selling.
Harmony Biosciences Holdings, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Valor IV Pharma Holdings, LLC (TenPercentOwner) — 3 transactions totaling $139,391,500
- Marshman Fund Trust II (TenPercentOwner) — 2 transactions totaling $139,391,500
- Dierks Jeffrey (CHIEF COMMERCIAL OFFICER) — 53 transactions totaling $11,040,390
- Kapadia Sandip (CHIEF FINANCIAL OFFICER) — 40 transactions totaling $7,929,628
- Dayno Jeffrey M. (PRESIDENT, CEO) — 24 transactions totaling $2,695,292
View all SEC Filings for Harmony Biosciences Holdings, Inc. (HRMY).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 3746 | $37.15 | 24,521.0000 | 58,544,570 | 13.25% | 0.01% |
| Jan. 24, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2500 | $0.00 | 2,500.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 24, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 1116 | $36.82 | 1,384.0000 | 58,544,570 | 44.64% | 0.00% |
| Jan. 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2600 | $0.00 | 2,600.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 1126 | $36.82 | 1,474.0000 | 58,544,570 | 43.31% | 0.00% |
| Jan. 22, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 42600 | $0.00 | 42,600.0000 | 58,544,570 | 9999.99% | 0.07% |
| Jan. 22, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Units | 12200 | $0.00 | 12,200.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 24, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2500 | $0.00 | 5,000.0000 | 58,544,570 | 33.33% | 0.00% |
| Jan. 25, 2026 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2600 | $0.00 | 7,800.0000 | 58,544,570 | 25.00% | 0.00% |
| Jan. 24, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Common Stock | 2188 | $0.00 | 2,188.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 24, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | F | Common Stock | 1153 | $36.82 | 1,035.0000 | 58,544,570 | 52.70% | 0.00% |
| Jan. 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Common Stock | 2662 | $0.00 | 2,662.0000 | 58,544,570 | 9999.99% | 0.00% |
| Jan. 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | F | Common Stock | 1372 | $36.82 | 1,290.0000 | 58,544,570 | 51.54% | 0.00% |
| Jan. 22, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Stock Option | 42600 | $0.00 | 42,600.0000 | 58,544,570 | 9999.99% | 0.07% |
| Jan. 22, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 12200 | $0.00 | 12,200.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 24, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 2188 | $0.00 | 4,175.0000 | 58,544,570 | 34.39% | 0.00% |
| Jan. 25, 2026 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 2662 | $0.00 | 7,988.0000 | 58,544,570 | 25.00% | 0.00% |
| Jan. 22, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Stock Option | 56900 | $0.00 | 56,900.0000 | 58,544,570 | 9999.99% | 0.10% |
| Jan. 22, 2026 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 16200 | $0.00 | 16,200.0000 | 58,544,570 | 9999.99% | 0.03% |
| Jan. 24, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 3813 | $0.00 | 3,813.0000 | 58,544,570 | 9999.99% | 0.01% |
| Jan. 24, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2239 | $36.82 | 1,574.0000 | 58,544,570 | 58.72% | 0.00% |
| Jan. 25, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 4725 | $0.00 | 4,725.0000 | 58,544,570 | 9999.99% | 0.01% |
| Jan. 25, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2553 | $36.82 | 2,172.0000 | 58,544,570 | 54.03% | 0.00% |
| Jan. 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Restricted Stock Units | 13000 | $0.00 | 39,000.0000 | 58,544,570 | 25.00% | 0.02% |
| Jan. 24, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Restricted Stock Units | 10500 | $0.00 | 21,000.0000 | 58,544,570 | 33.33% | 0.02% |
| Jan. 22, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Restricted Stock Units | 52900 | $0.00 | 52,900.0000 | 58,544,570 | 9999.99% | 0.09% |
| Jan. 22, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Stock Option | 184600 | $0.00 | 184,600.0000 | 58,544,570 | 9999.99% | 0.32% |
| Jan. 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | F | Common Stock | 5654 | $36.82 | 7,346.0000 | 58,544,570 | 43.49% | 0.01% |
| Jan. 25, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Common Stock | 13000 | $0.00 | 13,000.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 24, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | F | Common Stock | 4785 | $36.82 | 5,715.0000 | 58,544,570 | 45.57% | 0.01% |
| Jan. 24, 2026 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Common Stock | 10500 | $0.00 | 10,500.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 25, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 4725 | $0.00 | 14,175.0000 | 58,544,570 | 25.00% | 0.01% |
| Jan. 24, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3813 | $0.00 | 7,625.0000 | 58,544,570 | 33.34% | 0.01% |
| Jan. 22, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 42600 | $0.00 | 42,600.0000 | 58,544,570 | 9999.99% | 0.07% |
| Jan. 22, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 12200 | $0.00 | 12,200.0000 | 58,544,570 | 9999.99% | 0.02% |
| Jan. 15, 2026 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 20961 | $35.92 | 0.0000 | 58,544,570 | 100.00% | 0.04% |
| Dec. 12, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Stock Option | 20000 | $0.00 | 0.0000 | 58,717,910 | 100.00% | 0.03% |
| Dec. 12, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Common Stock | 20000 | $8.22 | 20,000.0000 | 58,717,910 | 9999.99% | 0.03% |
| Dec. 12, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | S | Common Stock | 20000 | $40.11 | 0.0000 | 58,717,910 | 100.00% | 0.03% |
| Dec. 12, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | S | Common Stock | 5933 | $40.11 | 0.0000 | 58,717,910 | 100.00% | 0.01% |
| Dec. 5, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Stock Option | 20000 | $0.00 | 185,000.0000 | 58,717,910 | 9.76% | 0.03% |
| Dec. 5, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 20000 | $29.03 | 20,000.0000 | 58,717,910 | 9999.99% | 0.03% |
| Dec. 5, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 20000 | $39.54 | 0.0000 | 58,717,910 | 100.00% | 0.03% |
| Nov. 21, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 3427 | $35.00 | 0.0000 | 58,717,910 | 100.00% | 0.01% |
| Sept. 30, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 45000 | $0.00 | 45,000.0000 | 58,427,134 | 9999.99% | 0.08% |
| Sept. 30, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 45000 | $0.00 | 45,000.0000 | 58,427,134 | 50.00% | 0.08% |
| Sept. 30, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 24039 | $27.56 | 20,961.0000 | 58,427,134 | 53.42% | 0.04% |
| Aug. 28, 2025 | Valor IV Pharma Holdings, LLC | TenPercentOwner | J | Common Stock | 6618033 | $0.00 | 579,528.0000 | 58,427,134 | 91.95% | 11.33% |
| Aug. 15, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 21573 | $36.50 | 0.0000 | 58,427,134 | 100.00% | 0.04% |
| May 15, 2025 | Philip Ron M | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 15, 2025 | Gracias Antonio J. | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 15, 2025 | Sabater Juan A. | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 25, 2025 | Graf R. Mark | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 15, 2025 | Anastasiou Peter | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 15, 2025 | Szyper Linda M | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 15, 2025 | Sender Gary | Not found | A | Stock Option | 14522 | $0.00 | 14,522.0000 | 58,524,566 | 9999.99% | 0.02% |
| May 1, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | F | Common Stock | 8869 | $29.86 | 9,881.0000 | 58,524,566 | 47.30% | 0.02% |
| May 1, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Common Stock | 18750 | $0.00 | 18,750.0000 | 58,524,566 | 9999.99% | 0.03% |
| May 1, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 18750 | $0.00 | 18,750.0000 | 58,524,566 | 50.00% | 0.03% |
| April 7, 2025 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 58,524,566 | 9999.99% | 0.05% |
| April 7, 2025 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | Stock Option | 100000 | $0.00 | 100,000.0000 | 58,524,566 | 9999.99% | 0.17% |
| April 2, 2025 | Philip Ron M | Not found | A | Stock Option | 14077 | $0.00 | 14,077.0000 | 58,524,566 | 9999.99% | 0.02% |
| April 1, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 6247 | $32.48 | 740.0000 | 58,524,566 | 89.41% | 0.01% |
| April 1, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 740 | $33.12 | 0.0000 | 58,524,566 | 100.00% | 0.00% |
| March 29, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 57,869,915 | 50.00% | 0.03% |
| March 29, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 8014 | $33.19 | 6,986.0000 | 57,869,915 | 53.43% | 0.01% |
| March 29, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 15000 | $0.00 | 15,000.0000 | 57,869,915 | 9999.99% | 0.03% |
| March 3, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 4869 | $0.00 | 0.0000 | 57,869,915 | 100.00% | 0.01% |
| March 3, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 4869 | $8.22 | 4,869.0000 | 57,869,915 | 9999.99% | 0.01% |
| March 3, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 4369 | $32.61 | 500.0000 | 57,869,915 | 89.73% | 0.01% |
| March 3, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 500 | $33.23 | 0.0000 | 57,869,915 | 100.00% | 0.00% |
| Jan. 27, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1629 | $38.02 | 0.0000 | 57,869,915 | 100.00% | 0.00% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 13125 | $0.00 | 39,375.0000 | 57,869,915 | 25.00% | 0.02% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Restricted Stock Units | 2687 | $0.00 | 8,063.0000 | 57,869,915 | 25.00% | 0.00% |
| Jan. 25, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A | Stock Option | 47200 | $0.00 | 47,200.0000 | 57,869,915 | 9999.99% | 0.08% |
| Jan. 24, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | F | Common Stock | 865 | $38.01 | 1,635.0000 | 57,869,915 | 34.60% | 0.00% |
| Jan. 24, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Common Stock | 2500 | $0.00 | 2,500.0000 | 57,869,915 | 9999.99% | 0.00% |
| Jan. 25, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Units | 10400 | $0.00 | 10,400.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 25, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 36500 | $0.00 | 36,500.0000 | 57,869,915 | 9999.99% | 0.06% |
| Jan. 24, 2025 | Serafin Andrew | CHIEF STRATEGY OFFICER | M | Restricted Stock Units | 2500 | $0.00 | 7,500.0000 | 57,869,915 | 25.00% | 0.00% |
| Jan. 25, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 18900 | $0.00 | 18,900.0000 | 57,869,915 | 9999.99% | 0.03% |
| Jan. 25, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 66250 | $0.00 | 66,250.0000 | 57,869,915 | 9999.99% | 0.11% |
| Jan. 24, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3812 | $0.00 | 11,438.0000 | 57,869,915 | 25.00% | 0.01% |
| Jan. 27, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 1775 | $38.05 | 0.0000 | 57,869,915 | 100.00% | 0.00% |
| Jan. 24, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 2037 | $38.01 | 1,775.0000 | 57,869,915 | 53.44% | 0.00% |
| Jan. 24, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 3812 | $0.00 | 3,812.0000 | 57,869,915 | 9999.99% | 0.01% |
| Jan. 25, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Restricted Stock Units | 52000 | $0.00 | 52,000.0000 | 57,869,915 | 9999.99% | 0.09% |
| Jan. 25, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Stock Option | 180000 | $0.00 | 180,000.0000 | 57,869,915 | 9999.99% | 0.31% |
| Jan. 24, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Restricted Stock Units | 10500 | $0.00 | 31,500.0000 | 57,869,915 | 25.00% | 0.02% |
| Jan. 24, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | F | Common Stock | 4567 | $38.01 | 5,933.0000 | 57,869,915 | 43.50% | 0.01% |
| Jan. 24, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Common Stock | 10500 | $0.00 | 10,500.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 25, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 13450 | $0.00 | 13,450.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 24, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Common Stock | 2187 | $0.00 | 2,187.0000 | 57,869,915 | 9999.99% | 0.00% |
| Jan. 24, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | F | Common Stock | 1151 | $38.01 | 1,036.0000 | 57,869,915 | 52.63% | 0.00% |
| Jan. 24, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 2187 | $0.00 | 6,563.0000 | 57,869,915 | 24.99% | 0.00% |
| Jan. 25, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Stock Option | 37400 | $0.00 | 37,400.0000 | 57,869,915 | 9999.99% | 0.06% |
| Jan. 25, 2025 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 10650 | $0.00 | 10,650.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 13125 | $30.69 | 13,125.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 8000 | $36.94 | 5,125.0000 | 57,869,915 | 60.95% | 0.01% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 5125 | $37.87 | 0.0000 | 57,869,915 | 100.00% | 0.01% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 2687 | $0.00 | 2,687.0000 | 57,869,915 | 9999.99% | 0.00% |
| Jan. 24, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | F | Common Stock | 1058 | $38.01 | 1,629.0000 | 57,869,915 | 39.37% | 0.00% |
| Jan. 21, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Common Stock | 19293 | $8.22 | 19,293.0000 | 57,869,915 | 9999.99% | 0.03% |
| Jan. 21, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Stock Option | 25000 | $0.00 | 205,000.0000 | 57,869,915 | 10.87% | 0.04% |
| Jan. 21, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | S | Common Stock | 25000 | $40.18 | 0.0000 | 57,869,915 | 100.00% | 0.04% |
| Jan. 21, 2025 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 25000 | $29.03 | 25,000.0000 | 57,869,915 | 9999.99% | 0.04% |
| Jan. 21, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | S | Common Stock | 19293 | $40.13 | 0.0000 | 57,869,915 | 100.00% | 0.03% |
| Jan. 21, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Stock Option | 3470 | $0.00 | 20,000.0000 | 57,869,915 | 14.78% | 0.01% |
| Jan. 21, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Stock Option | 6086 | $0.00 | 0.0000 | 57,869,915 | 100.00% | 0.01% |
| Jan. 21, 2025 | Dayno Jeffrey M. | PRESIDENT, CEO | M | Stock Option | 9737 | $0.00 | 2,435.0000 | 57,869,915 | 80.00% | 0.02% |
| Jan. 16, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 29475 | $0.00 | 6,738.0000 | 57,869,915 | 81.39% | 0.05% |
| Jan. 21, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 1123 | $0.00 | 5,615.0000 | 57,869,915 | 16.67% | 0.00% |
| Jan. 16, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 29475 | $33.44 | 29,475.0000 | 57,869,915 | 9999.99% | 0.05% |
| Jan. 16, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 29475 | $37.41 | 0.0000 | 57,869,915 | 100.00% | 0.05% |
| Jan. 21, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 1123 | $33.44 | 1,123.0000 | 57,869,915 | 9999.99% | 0.00% |
| Jan. 21, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1123 | $40.00 | 0.0000 | 57,869,915 | 100.00% | 0.00% |
| Jan. 15, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 10507 | $0.00 | 36,213.0000 | 57,869,915 | 22.49% | 0.02% |
| Jan. 15, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 10507 | $33.44 | 10,507.0000 | 57,869,915 | 9999.99% | 0.02% |
| Jan. 15, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 10507 | $37.01 | 0.0000 | 57,869,915 | 100.00% | 0.02% |
| Jan. 13, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 7180 | $0.00 | 46,720.0000 | 57,869,915 | 13.32% | 0.01% |
| Jan. 13, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 7180 | $33.44 | 7,180.0000 | 57,869,915 | 9999.99% | 0.01% |
| Jan. 13, 2025 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 7180 | $37.04 | 0.0000 | 57,869,915 | 100.00% | 0.01% |
| Nov. 1, 2024 | Marshman Fund Trust II | TenPercentOwner | S | Common Stock | 4000000 | $30.30 | 6,651,120.0000 | 58,103,963 | 37.55% | 6.88% |
| Nov. 1, 2024 | Valor IV Pharma Holdings, LLC | TenPercentOwner | S | Common Stock | 4000000 | $30.30 | 7,218,033.0000 | 58,103,963 | 35.66% | 6.88% |
| Nov. 5, 2024 | Marshman Fund Trust II | TenPercentOwner | S | Common Stock | 600000 | $30.30 | 6,051,120.0000 | 58,103,963 | 9.02% | 1.03% |
| Nov. 5, 2024 | Valor IV Pharma Holdings, LLC | TenPercentOwner | S | Common Stock | 600000 | $30.30 | 6,618,033.0000 | 58,103,963 | 8.31% | 1.03% |
| Oct. 29, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 21496 | $40.47 | 0.0000 | 58,103,963 | 100.00% | 0.04% |
| Oct. 29, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 21496 | $24.00 | 21,496.0000 | 58,103,963 | 9999.99% | 0.04% |
| Oct. 29, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 21496 | $0.00 | 28,972.0000 | 58,103,963 | 42.59% | 0.04% |
| Oct. 3, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 705 | $35.62 | 0.0000 | 58,103,963 | 100.00% | 0.00% |
| Oct. 3, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 35652 | $35.05 | 705.0000 | 58,103,963 | 98.06% | 0.06% |
| Oct. 1, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 400 | $40.19 | 0.0000 | 58,103,963 | 100.00% | 0.00% |
| Oct. 1, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 400 | $24.00 | 400.0000 | 58,103,963 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 400 | $0.00 | 50,468.0000 | 58,103,963 | 0.79% | 0.00% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 60000 | $0.00 | 60,000.0000 | 57,541,696 | 9999.99% | 0.10% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | F | Common Stock | 23643 | $40.00 | 36,357.0000 | 57,541,696 | 39.41% | 0.04% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Restricted Stock Units | 60000 | $0.00 | 90,000.0000 | 57,541,696 | 40.00% | 0.10% |
| Sept. 30, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 60000 | $0.00 | 60,000.0000 | 57,541,696 | 9999.99% | 0.10% |
| Sept. 30, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 32052 | $40.00 | 27,948.0000 | 57,541,696 | 53.42% | 0.06% |
| Sept. 30, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 60000 | $0.00 | 90,000.0000 | 57,541,696 | 40.00% | 0.10% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 35846 | $24.00 | 35,846.0000 | 57,541,696 | 9999.99% | 0.06% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 35846 | $40.03 | 0.0000 | 57,541,696 | 100.00% | 0.06% |
| Sept. 30, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 35846 | $0.00 | 50,868.0000 | 57,541,696 | 41.34% | 0.06% |
| Sept. 27, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 200 | $24.00 | 200.0000 | 57,541,696 | 9999.99% | 0.00% |
| Sept. 27, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 200 | $40.05 | 0.0000 | 57,541,696 | 100.00% | 0.00% |
| Sept. 27, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 200 | $0.00 | 86,714.0000 | 57,541,696 | 0.23% | 0.00% |
| May 29, 2024 | Anastasiou Peter | Not found | A | Stock Option | 6336 | $0.00 | 6,336.0000 | 57,597,627 | 9999.99% | 0.01% |
| May 29, 2024 | Szyper Linda M | Not found | A | Stock Option | 6336 | $0.00 | 6,336.0000 | 57,597,627 | 9999.99% | 0.01% |
| May 29, 2024 | Sender Gary | Not found | A | Stock Option | 11657 | $0.00 | 11,657.0000 | 57,597,627 | 9999.99% | 0.02% |
| May 29, 2024 | Gracias Antonio J. | Not found | A | Stock Option | 8870 | $0.00 | 8,870.0000 | 57,597,627 | 9999.99% | 0.02% |
| May 29, 2024 | Sabater Juan A. | Not found | A | Stock Option | 6336 | $0.00 | 6,336.0000 | 57,597,627 | 9999.99% | 0.01% |
| May 29, 2024 | Graf R. Mark | Not found | A | Stock Option | 6336 | $0.00 | 6,336.0000 | 57,597,627 | 9999.99% | 0.01% |
| May 29, 2024 | Nielsen Jack | Not found | A | Stock Option | 6336 | $0.00 | 6,336.0000 | 57,597,627 | 9999.99% | 0.01% |
| May 1, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Stock Option | 75000 | $0.00 | 75,000.0000 | 57,597,627 | 9999.99% | 0.13% |
| May 1, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 57,597,627 | 9999.99% | 0.13% |
| March 29, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 15000 | $0.00 | 15,000.0000 | 60,372,397 | 50.00% | 0.02% |
| March 29, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | Common Stock | 8013 | $33.58 | 6,987.0000 | 60,372,397 | 53.42% | 0.01% |
| March 29, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | Common Stock | 15000 | $0.00 | 15,000.0000 | 60,372,397 | 9999.99% | 0.02% |
| March 15, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 9644 | $0.00 | 4,869.0000 | 60,372,397 | 66.45% | 0.02% |
| March 15, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 2335 | $0.00 | 0.0000 | 60,372,397 | 100.00% | 0.00% |
| March 15, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 11979 | $32.00 | 0.0000 | 60,372,397 | 100.00% | 0.02% |
| March 15, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 11979 | $8.22 | 11,979.0000 | 60,372,397 | 9999.99% | 0.02% |
| March 8, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 94 | $0.00 | 14,513.0000 | 60,372,397 | 0.64% | 0.00% |
| March 8, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Common Stock | 194 | $8.22 | 194.0000 | 60,372,397 | 9999.99% | 0.00% |
| March 8, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | S | Common Stock | 194 | $32.00 | 0.0000 | 60,372,397 | 100.00% | 0.00% |
| March 8, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | M | Stock Option | 100 | $0.00 | 2,335.0000 | 60,372,397 | 4.11% | 0.00% |
| Jan. 24, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 10750 | $0.00 | 10,750.0000 | 60,372,397 | 9999.99% | 0.02% |
| Jan. 24, 2024 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Stock Option | 47750 | $0.00 | 47,750.0000 | 60,372,397 | 9999.99% | 0.08% |
| Jan. 24, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Stock Option | 42500 | $0.00 | 42,500.0000 | 60,372,397 | 9999.99% | 0.07% |
| Jan. 24, 2024 | Serafin Andrew | CHIEF STRATEGY OFFICER | A | Restricted Stock Unit | 10000 | $0.00 | 10,000.0000 | 60,372,397 | 9999.99% | 0.02% |
| Jan. 24, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Stock Option | 74250 | $0.00 | 74,250.0000 | 60,372,397 | 9999.99% | 0.12% |
| Jan. 24, 2024 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 15250 | $0.00 | 15,250.0000 | 60,372,397 | 9999.99% | 0.03% |
| Jan. 24, 2024 | Budur Kumar | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 8750 | $0.00 | 8,750.0000 | 60,372,397 | 9999.99% | 0.01% |
| Jan. 24, 2024 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Stock Option | 202250 | $0.00 | 202,250.0000 | 60,372,397 | 9999.99% | 0.34% |
| Jan. 24, 2024 | Dayno Jeffrey M. | PRESIDENT, CEO | A | Restricted Stock Units | 42000 | $0.00 | 42,000.0000 | 60,372,397 | 9999.99% | 0.07% |
| Jan. 24, 2024 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | A | Stock Option | 52500 | $0.00 | 52,500.0000 | 60,372,397 | 9999.99% | 0.09% |